Orlova, R., Vakhitova, A., Gluzman, M., Topuzov, E., Krivorotko, P., Androsova, A., Serikova, E., Skvortsov, V. (2025). Results of the prospective randomized controlled trial VOG-01: Neoadjuvant endocrine therapy ribociclib + fulvestrant + GnRH-a versus chemotherapy 4 AC + 4 T for early HR+/HER2-negative breast cancer in premenopausal patients.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.606